The Insulin Resistance Intervention after Stroke trial: a perspective on future practice and research

The prevention of recurrent events after ischaemic stroke and transient ischaemic attack is well established and based on lifestyle changes, antithrombotics, statins, antihypertensives and carotid surgery. The international IRIS trial assessed whether pioglitazone, a glucose-lowering insulin-sensiti...

Full description

Bibliographic Details
Main Authors: Bath, Philip M.W., Appleton, Jason P., Sprigg, Nikola
Format: Article
Published: SAGE Publications 2016
Subjects:
Online Access:https://eprints.nottingham.ac.uk/35498/
_version_ 1848795093159378944
author Bath, Philip M.W.
Appleton, Jason P.
Sprigg, Nikola
author_facet Bath, Philip M.W.
Appleton, Jason P.
Sprigg, Nikola
author_sort Bath, Philip M.W.
building Nottingham Research Data Repository
collection Online Access
description The prevention of recurrent events after ischaemic stroke and transient ischaemic attack is well established and based on lifestyle changes, antithrombotics, statins, antihypertensives and carotid surgery. The international IRIS trial assessed whether pioglitazone, a glucose-lowering insulin-sensitizing drug, would reduce recurrent vascular events in patients with ischaemic stroke or transient ischaemic attack. After 4.8 years, pioglitazone therapy was associated with reduced vascular events and new diabetes, and an increase in weight, oedema and bone fractures. Pioglitazone may add to the strategies for preventing further events in patients with stroke or transient ischaemic attack.
first_indexed 2025-11-14T19:26:36Z
format Article
id nottingham-35498
institution University of Nottingham Malaysia Campus
institution_category Local University
last_indexed 2025-11-14T19:26:36Z
publishDate 2016
publisher SAGE Publications
recordtype eprints
repository_type Digital Repository
spelling nottingham-354982020-05-04T18:01:48Z https://eprints.nottingham.ac.uk/35498/ The Insulin Resistance Intervention after Stroke trial: a perspective on future practice and research Bath, Philip M.W. Appleton, Jason P. Sprigg, Nikola The prevention of recurrent events after ischaemic stroke and transient ischaemic attack is well established and based on lifestyle changes, antithrombotics, statins, antihypertensives and carotid surgery. The international IRIS trial assessed whether pioglitazone, a glucose-lowering insulin-sensitizing drug, would reduce recurrent vascular events in patients with ischaemic stroke or transient ischaemic attack. After 4.8 years, pioglitazone therapy was associated with reduced vascular events and new diabetes, and an increase in weight, oedema and bone fractures. Pioglitazone may add to the strategies for preventing further events in patients with stroke or transient ischaemic attack. SAGE Publications 2016-07-12 Article PeerReviewed Bath, Philip M.W., Appleton, Jason P. and Sprigg, Nikola (2016) The Insulin Resistance Intervention after Stroke trial: a perspective on future practice and research. International Journal of Stroke . ISSN 1747-4949 Prevention Ischaemic Stroke Clinical Trial Stroke Treatment Vascular Events http://wso.sagepub.com/content/early/2016/07/12/1747493016660099 doi:10.1177/1747493016660099 doi:10.1177/1747493016660099
spellingShingle Prevention
Ischaemic Stroke
Clinical Trial
Stroke
Treatment
Vascular Events
Bath, Philip M.W.
Appleton, Jason P.
Sprigg, Nikola
The Insulin Resistance Intervention after Stroke trial: a perspective on future practice and research
title The Insulin Resistance Intervention after Stroke trial: a perspective on future practice and research
title_full The Insulin Resistance Intervention after Stroke trial: a perspective on future practice and research
title_fullStr The Insulin Resistance Intervention after Stroke trial: a perspective on future practice and research
title_full_unstemmed The Insulin Resistance Intervention after Stroke trial: a perspective on future practice and research
title_short The Insulin Resistance Intervention after Stroke trial: a perspective on future practice and research
title_sort insulin resistance intervention after stroke trial: a perspective on future practice and research
topic Prevention
Ischaemic Stroke
Clinical Trial
Stroke
Treatment
Vascular Events
url https://eprints.nottingham.ac.uk/35498/
https://eprints.nottingham.ac.uk/35498/
https://eprints.nottingham.ac.uk/35498/